Dry eye signs and symptoms in patients on aromatase inhibitor therapy.
Pauline KhooThomas GroeneveldFrances BoyleSiobhan O'NeillBenjamin ForsterStephanie L WatsonPublished in: Eye (London, England) (2021)
Our study found increased tear osmolarity and meibomian gland drop out in women on AI with symptomatic dry eye. Longer duration of AI therapy and higher tear osmolarity may increase the risk of developing dry eye.
Keyphrases
- end stage renal disease
- artificial intelligence
- newly diagnosed
- ejection fraction
- chronic kidney disease
- peritoneal dialysis
- prognostic factors
- polycystic ovary syndrome
- type diabetes
- mesenchymal stem cells
- patient reported outcomes
- physical activity
- pregnant women
- metabolic syndrome
- depressive symptoms
- bone marrow
- skeletal muscle
- smoking cessation